Yucca Health Tirzepatide Review

Yucca Health—found at tryyucca.com and operated by Yucca Health, Inc.—is one of the better-documented newer GLP-1 telehealth services. Our research (checked July 25, 2026) verified named physicians, published clinical eligibility criteria, real review volume, and plan pricing—along with refund mechanics worth understanding before prepaying.

Medications and Verified Pricing

From Yucca's pages as of July 2026 (both GLP-1 formulations include a B12 boost):

• Compounded semaglutide+B12—$146/month "for life" with code YUCCA4LIFE, or a six-month plan at $750 total ($125/month effective)
• Compounded tirzepatide+B12—$258/month, or six months at $1,350 ($225/month effective)
• NAD+ and sermorelin—from $158 (3-month supplies); peptides listed as coming soon

Plans include licensed providers in all 50 states, provider review within 24 hours, a patient portal, and free expedited 2-day UPS shipping. Affirm financing is available.

Rare Clinical Transparency

Two things most competitors don't publish: Yucca names its physicians—Dr. Michael Wasef, MD and Dr. Andrew Sakla, DO, both board-certified in internal medicine (University of South Florida)—and it publishes its eligibility criteria: BMI 30+, or 27+ with a weight-related condition, with BMI 25+ considered case-by-case. Publishing real clinical gates is a genuinely good sign in a category where some services take anyone with a card. LegitScript and HIPAA badges are displayed, and its own FDA disclaimer is direct: compounded medications are not FDA-approved and don't undergo FDA review for safety, effectiveness, or manufacturing quality.

The Real Review Record—and the Refund Mechanics

Yucca's Trustpilot profile holds roughly 1,000 reviews at about 4.6 stars—a genuine, substantial record with consistent praise for customer service and results (its on-site badges cite 4.7 Trustpilot and 4.8 Google, close to the live numbers, which is more honest than most). The documented complaints are specific and worth knowing: one customer whom Yucca agreed deserved a partial refund reported being pushed toward store credit instead of a real refund, and another described Affirm-financing confusion where the lender claimed a balance after payoff. No refund or cancellation terms are published on the main pages, and the pharmacies are unnamed. Before prepaying a six-month plan—or financing one through Affirm—get the refund terms in writing and understand what happens to unused months.

Critical 2026 Regulatory Context

In 2026 the FDA proposed excluding semaglutide and tirzepatide from the 503B bulks list, restricting mass GLP-1 compounding. Confirm current availability and sourcing before enrolling.

Important: Compounded Medications

Yucca states it plainly: its compounded medications are prepared by licensed U.S. pharmacies, are not FDA-approved, and do not undergo FDA review. Self-reported platform figures (20,000+ active patients, 100,000+ prescriptions) are company marketing. Consult your own physician before starting.